Pyxis Oncology, Inc. Common Stock (PYXS) is a publicly traded Healthcare sector company. As of May 21, 2026, PYXS trades at $2.00 with a market cap of $127.98M and a P/E ratio of -1.47. PYXS moved +4.71% today. Year to date, PYXS is +65.29%; over the trailing twelve months it is +65.29%. Its 52-week range spans $0.83 to $5.55. Analyst consensus is strong buy with an average price target of $6.33. Rallies surfaces PYXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PYXS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PYXS recently traded at $2.00. Market cap is $127.98M. P/E ratio is -1.47. Revenue is $13.86M.
| Metric | Value |
|---|---|
| Price | $2.00 |
| Market Cap | $127.98M |
| P/E Ratio | -1.47 |
| EPS | $-1.31 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.55 |
| 52-Week Low | $0.83 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $13.86M |
| Net Income | $-81.73M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $13.86M | $-79.62M | $-1.28 |
| 2024 | $16.15M | $-77.33M | $-1.32 |
| 2023 | $0 | $-73.79M | $-1.85 |
| 2022 | $0 | $-120.72M | $-3.65 |
7 analysts cover PYXS: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.33.